Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M339Revenue $M0Net Margin (%)-13,298.4Z-Score0
Enterprise Value $M313EPS $0Operating Margin %-12,709.7F-Score0
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-13,298.4Higher ROA y-yN
Price/Book010-y EBITDA Growth Rate %0Quick Ratio5.0Cash flow > EarningsN
Price/Sales2,0135-y EBITDA Growth Rate %0Current Ratio5.0Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-68.8Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)3ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M0ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with OCUL

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

OCUL is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


OCUL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SVLSF IV, LLC10% Owner 2014-07-30Buy715,380$1321.46 view
Sawhney AmarpreetPresident and CEO, 10% Owner 2014-07-30Buy76,922$1321.46 view
CHV II, L.P.10% Owner 2014-07-30Buy153,846$1321.46 view

Press Releases about OCUL :

    Quarterly/Annual Reports about OCUL:

    News about OCUL:

    Articles On GuruFocus.com
    Weekly CEO Buys Highlight: APD, OCUL, CNMD, OPK, AEGR Aug 04 2014 

    More From Other Websites
    Ocular Therapeutix to Present at the 21st Annual NewsMakers in the Biotech Industry Investment... Sep 16 2014
    Ocular Therapeutix to Present at Morgan Stanley 2014 Global Healthcare Conference Sep 03 2014
    OCULAR THERAPEUTIX, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Aug 29 2014
    Ocular Therapeutix Announces Second Quarter 2014 Financial Results Aug 28 2014
    Ocular Therapeutix Announces Exercise of Over-Allotment Option Aug 19 2014
    Coverage initiated on Ocular Therapeutix by RBC Capital Mkts and Oppenheimer Aug 19 2014
    Ocular Therapeutix (NASDAQ: OCUL) to Ring The NASDAQ Stock Market Closing Bell Jul 31 2014
    Ocular Therapeutix Announces Closing of Initial Public Offering Jul 30 2014
    OCULAR THERAPEUTIX, INC Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to... Jul 30 2014
    Stocks drop as Amazon and other earnings report disappoint Jul 25 2014
    IPO Stock Watch: Biotechs Struggle To Get Out Door Jul 25 2014
    IPOs Gear Up But See Tepid Pricing Jul 25 2014
    IPOs off to damp start (again) ahead of tidal wave Jul 25 2014
    IPO Preview: Ocular Therapeutix Jul 25 2014
    Ocular Therapeutix Prices Initial Public Offering Jul 24 2014
    IPO Stock Watch: Biotechs Are Half Of July Calendar Jul 23 2014
    July Biotech Blitz And The Upcoming Eye, Ear And Nose IPOs Jul 23 2014
    Watch Closely For Ocular Therapeutix IPO Jul 23 2014
    IPO Lookout: Lots of Action This Week, But Is Anything A Worthwhile Investment? Jul 21 2014
    IPO Calendar: Biotechs Sizzle With 7 New Issues Jul 21 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK